Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells. 2008

Gustavo H Kijak, and Luiz Mario Janini, and Sodsai Tovanabutra, and Eric Sanders-Buell, and Miguel Angel Arroyo, and Merlin L Robb, and Nelson L Michael, and Debora L Birx, and Francine E McCutchan
Henry M. Jackson Foundation for the Advancement of Military Medicine/US Military HIV Research Program, 1600 East Gude Drive, Rockville, Maryland 20850, USA. gkijak@hivresearch.org

APOBEC-mediated cytidine deamination of HIV-1 genomes during reverse transcription has been shown to be a potent mechanism of host restriction for HIV-1 infection ex vivo and in vitro. However, this defense system can be overcome by the viral protein Vif. Unlike other mechanisms of host restriction, the APOCEC-Vif interaction leaves an imprint on integrated proviruses in the form of G-->A hypermutation. In the current work we systematically studied levels, contexts, and patterns of HIV-1 hypermutation in vivo. The analysis of 24 full-genome HIV-1 sequences retrieved from primary PBMCs, representing infections with several HIV-1 clades, and the inclusion of 7 cognate pairs of hypermutated/non-hypermutated sequences derived from the same patient sample, provided a comprehensive view of the characteristics of APOBEC-mediated restriction in vivo. Levels of hypermutation varied nearly 5-fold among the studied proviruses. GpG motifs were most frequently affected (22/24 proviruses). Levels of hypermutation varied across the genome. The reported "twin peak" pattern of hypermutation was observed in 18/24 hypermutants, but the remainder exhibited singular non-conforming patterns. These data suggest considerable complexity in the interplay of host restriction and viral defense during HIV-1 infection.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011533 Proviruses Duplex DNA sequences in eukaryotic chromosomes, corresponding to the genome of a virus, that are transmitted from one cell generation to the next without causing lysis of the host. Proviruses are often associated with neoplastic cell transformation and are key features of retrovirus biology. Provirus
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016679 Genome, Viral The complete genetic complement contained in a DNA or RNA molecule in a virus. Viral Genome,Genomes, Viral,Viral Genomes
D017422 Sequence Analysis, DNA A multistage process that includes cloning, physical mapping, subcloning, determination of the DNA SEQUENCE, and information analysis. DNA Sequence Analysis,Sequence Determination, DNA,Analysis, DNA Sequence,DNA Sequence Determination,DNA Sequence Determinations,DNA Sequencing,Determination, DNA Sequence,Determinations, DNA Sequence,Sequence Determinations, DNA,Analyses, DNA Sequence,DNA Sequence Analyses,Sequence Analyses, DNA,Sequencing, DNA

Related Publications

Gustavo H Kijak, and Luiz Mario Janini, and Sodsai Tovanabutra, and Eric Sanders-Buell, and Miguel Angel Arroyo, and Merlin L Robb, and Nelson L Michael, and Debora L Birx, and Francine E McCutchan
June 1993, AIDS (London, England),
Gustavo H Kijak, and Luiz Mario Janini, and Sodsai Tovanabutra, and Eric Sanders-Buell, and Miguel Angel Arroyo, and Merlin L Robb, and Nelson L Michael, and Debora L Birx, and Francine E McCutchan
May 2023, Pathogens (Basel, Switzerland),
Gustavo H Kijak, and Luiz Mario Janini, and Sodsai Tovanabutra, and Eric Sanders-Buell, and Miguel Angel Arroyo, and Merlin L Robb, and Nelson L Michael, and Debora L Birx, and Francine E McCutchan
March 1993, Journal of acquired immune deficiency syndromes,
Gustavo H Kijak, and Luiz Mario Janini, and Sodsai Tovanabutra, and Eric Sanders-Buell, and Miguel Angel Arroyo, and Merlin L Robb, and Nelson L Michael, and Debora L Birx, and Francine E McCutchan
August 1993, PCR methods and applications,
Gustavo H Kijak, and Luiz Mario Janini, and Sodsai Tovanabutra, and Eric Sanders-Buell, and Miguel Angel Arroyo, and Merlin L Robb, and Nelson L Michael, and Debora L Birx, and Francine E McCutchan
January 2014, Methods in molecular biology (Clifton, N.J.),
Gustavo H Kijak, and Luiz Mario Janini, and Sodsai Tovanabutra, and Eric Sanders-Buell, and Miguel Angel Arroyo, and Merlin L Robb, and Nelson L Michael, and Debora L Birx, and Francine E McCutchan
December 1997, Journal of virological methods,
Gustavo H Kijak, and Luiz Mario Janini, and Sodsai Tovanabutra, and Eric Sanders-Buell, and Miguel Angel Arroyo, and Merlin L Robb, and Nelson L Michael, and Debora L Birx, and Francine E McCutchan
October 1993, Journal of acquired immune deficiency syndromes,
Gustavo H Kijak, and Luiz Mario Janini, and Sodsai Tovanabutra, and Eric Sanders-Buell, and Miguel Angel Arroyo, and Merlin L Robb, and Nelson L Michael, and Debora L Birx, and Francine E McCutchan
January 1991, Journal of acquired immune deficiency syndromes,
Gustavo H Kijak, and Luiz Mario Janini, and Sodsai Tovanabutra, and Eric Sanders-Buell, and Miguel Angel Arroyo, and Merlin L Robb, and Nelson L Michael, and Debora L Birx, and Francine E McCutchan
April 1995, AIDS (London, England),
Gustavo H Kijak, and Luiz Mario Janini, and Sodsai Tovanabutra, and Eric Sanders-Buell, and Miguel Angel Arroyo, and Merlin L Robb, and Nelson L Michael, and Debora L Birx, and Francine E McCutchan
September 2010, Virology,
Copied contents to your clipboard!